Why the study?
Does trandolapril provide better 24-h antihypertensive coverage and residual blood pressure lowering after dose omission compared to quinapril in patients with mild-to-moderate hypertension?
Does trandolapril provide better 24-h antihypertensive coverage and residual blood pressure lowering after dose omission compared to quinapril in patients with mild-to-moderate hypertension?
Trandolapril and quinapril provide similar 24-hour blood pressure control, but trandolapril has a longer duration of action, maintaining significant blood pressure lowering even after a missed dose.
Trandolapril may be preferred for adherence-challenged patients; extends RCT evidence on differential ACEI duration beyond 24 hours.
The duration of action of antihypertensive drugs may be assessed by several methods using ambulatory blood pressure monitoring (ABPM). The aim of this double-blind, randomized study was to compare the time-effect profile of once daily Trandolapril (Tra) 2 mg vs. Quinapril (Qui) 20 mg in 92 patients with mild-to-moderate hypertension. All patients received placebo during a 30-day run-in period followed by 2 months of active therapy and 1-day medication omission. ABPM was conducted on each period. 24 h antihypertensive coverage was assessed by trough:peak ratio (T/P) and smoothness index (SI) methods. Residual lowering of blood pressure after single-blind, 1 day medication omission was investigated as the SBP/DBP 48-h trough effect. There were no statistically significant differences between treatment groups in the mean SBP/DBP peak or trough effect. Individual T/P were not normally distributed and had very large variations explained by BP random- and activity-related fluctuations. Group T/P were 0.85 for Tra and 0.62 for Qui. The SI values were normally distributed and not statistically different between the two treatment groups. After dose omission, Qui was ineffective at 48-h trough while Tra retained a significant effect (SBP/DBP = -3.4/-4.3 mmHg) and this difference was even greater in ABPM-responders. Comparison of the trough:peak ratios and smoothness indexes of Tra and Qui failed to show any statistically significant difference on 24-h antihypertensive coverage. Nevertheless, residual lowering of blood pressure at 48-h trough suggests that Tra had a longer duration of action than Qui.
No takes yet. Share an insight, caveat, or question.
Radauceanu et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: